Yvo J.M. op den Kamp, Anne Gemmink, Marlies de Ligt, Bas Dautzenberg, Esther Kornips, Johanna A. Jorgensen, . . . Patrick Schrauwen. (2022). Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism. Elsevier.
Chicago Style (17th ed.) CitationYvo J.M. op den Kamp, et al. Effects of SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes on Skeletal Muscle Cellular Metabolism. Elsevier, 2022.
MLA (9th ed.) CitationYvo J.M. op den Kamp, et al. Effects of SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes on Skeletal Muscle Cellular Metabolism. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.